NEUROVANCE
Neurovance is a clinical-stage neuroscience company that discovered and developed centanafadine (CTN) to help adults and children with ADHD. Neurovance has been funded in a venture capital investment by Novartis Venture Fund, Venture Investors, Tekla Capital Management, GBS Venture Partners, State of Wisconsin Investment Board (SWIB), and Timothy J. Barberich. It was founded in 2009 and is headquartered in Cambridge, Massachusetts.
NEUROVANCE
Industry:
Biotechnology Clinical Trials Health Care Neuroscience
Founded:
2009-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.neurovance.com
Total Employee:
1+
Status:
Closed
Contact:
(617) 758-0300
Email Addresses:
[email protected]
Total Funding:
31.78 M USD
Technology used in webpage:
SPF Apache Microsoft Exchange Online Office 365 Mail Symantec Secure Site Citrix NetScaler Register.com DNS Confluence Networks
Similar Organizations
Alphamab Oncology
Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization.
Good Start Genetics
Good Start Genetics is a molecular genetic information company that has designed a proprietary tech platform to harness the power of NGS.
Minerva Neuroscience
Minerva Neurosciences is a clinical-stage biopharmaceutical company
Novaseek Research
Novaseek Research is a clinical data analytics and biospecimen sourcing, has developed a clinical data network platform for research.
Prothena
Prothena is a clinical-stage neuroscience company focused on the discovery and development of novel therapies.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
VBI Vaccines
VBI Vaccinea is a biopharmaceutical company developing novel technologies that seek to expand vaccine.
X4 Pharmaceuticals
X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment.
Current Advisors List
Current Employees Featured
Founder
Investors List
Venture Investors
Venture Investors investment in Series A - Neurovance
Venture Investors
Venture Investors investment in Series A - Neurovance
Timothy J. Barberich
Timothy J. Barberich investment in Series A - Neurovance
GBS Ventures
GBS Ventures investment in Series A - Neurovance
Novartis Venture Fund
Novartis Venture Fund investment in Series A - Neurovance
Tekla Capital Management
Tekla Capital Management investment in Series A - Neurovance
H&Q Healthcare Investors
H&Q Healthcare Investors investment in Series A - Neurovance
State of Wisconsin Investment Board
State of Wisconsin Investment Board investment in Series A - Neurovance
State of Wisconsin Investment Board
State of Wisconsin Investment Board investment in Venture Round - Neurovance
GBS Ventures
GBS Ventures investment in Venture Round - Neurovance
Official Site Inspections
http://www.neurovance.com
- Host name: a2b7bf3398455f345.awsglobalaccelerator.com
- IP address: 99.83.161.153
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Neurovance"
Neurovance - Crunchbase Company Profile & Funding
Neurovance is a clinical-stage neuroscience company that discovered and developed centanafadine (CTN) to help adults and children with ADHD. Neurovance has been funded in …See details»
Neurovance 2025 Company Profile: Valuation, Investors
Information on acquisition, funding, cap tables, investors, and executives for Neurovance. Use the PitchBook Platform to explore the full profile.See details»
Neurovance , Inc.: Contact Details and Business Profile
Neurovance , Inc. is a Pharmaceutical Manufacturing, Medical Devices & Equipment, and Drug Discovery company located in Cambridge, Massachusetts with $7.00 Million in revenue and …See details»
Neurovance - Headquarter Location, Corporate Office Address …
About. Neurovance is Drug Discovery in United States that focus on triple re business. Founded in 2011. They cover business area such as developer, lack, focus, inattention, disorganization, …See details»
Neurovance - Ownership and Business Overview - Mergr
Mar 3, 2017 Neurovance, Inc. is a clinical stage neuroscience-focused company. Hypothesis-driven, proprietary research at Neurovance discovered and developed centanafadine (CTN), a …See details»
neuroavance
Terapias mas breves y efectivas mas de 20 años experienciaSee details»
Neurovance - Company Profile - Tracxn
Mar 9, 2025 Neurovance - Drug to modulate neurochemicals to treat Attention Deficit Hyperactivity Disorder .. Acquired by Otsuka. Raised a total funding of $53M over 6 rounds …See details»
Neurovance, Inc.:Company Profile & Technical …
Neurovance, Inc. is a company that provides Neuroscience, Clinical trial, Central nervous system and more. Neurovance, Inc. is headquartered in United States Massachusetts.See details»
Neurovance - VentureRadar
Website: http://www.neurovance.com. Neurovance is a clinical stage neuroscience-focused company developing EB-1020 SR for adult attention deficit hyperactivity ...See details»
Neurovance - Products, Competitors, Financials, Employees, …
Headquarters Location. 43 Thorndike Street Suite S1-3. Cambridge, Massachusetts, 02141, United States. 617-758-0300See details»
Neurovance Inc - Company Profile and News - Bloomberg Markets
Company profile page for Neurovance Inc including stock price, company news, executives, board members, and contact informationSee details»
Neurovance, Inc. - Company Profile - Corporation Wiki
Neurovance, Inc. Overview. Neurovance, Inc. filed as a Domestic for Profit Corporation in the State of Florida on Friday, February 23, 2024 and is approximately six months old, as …See details»
Neurovance - Company Profile & Staff Directory - ContactOut
Neurovance is led by co-founder Anthony McKinney who is joined by a team of seasoned drug developers. Members of the management team participated in the development of Prozac, …See details»
About - Cerevance
Apr 1, 2025 Dr. Vaidya is a physician-scientist and drug developer with over 20 years of experience in academia, biotech and the pharmaceutical industry. Prior to Cerevance, Dr. …See details»
Otsuka Pharmaceutical to Acquire Neurovance, Inc.
Mar 3, 2017 Otsuka Pharmaceutical Co., Ltd. (OPC) today announces an agreement with Neurovance, Inc. (Neurovance) under which OPC has agreed to acquire Neurovance, a …See details»
Neurovance - Crunchbase
Neurovance is a clinical-stage neuroscience company that discovered and developed centanafadine (CTN) to help adults and children with ADHD.See details»
Neurovance - Contacts, Employees, Board Members, Advisors
Neurovance is a clinical-stage neuroscience company that discovered and developed centanafadine (CTN) to help adults and children with ADHD.See details»
Otsuka Holdings Acquires Neurovance | Mergr M&A Deal Summary
Mar 3, 2017 Neurovance, Inc. is a clinical stage neuroscience-focused company. Hypothesis-driven, proprietary research at Neurovance discovered and developed centanafadine (CTN), a …See details»
Neurovance - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
adultos - neuroavance
·Estrés y Ansiedad ·Miedos, Angustias, Fobias ·Bajo Estado de Ánimo, Inseguridad ·Timidez , Habilidades Sociales ·Baja Autoestima ·Insomnio ·Sentimientos de CulpaSee details»